How does sharewise work?
Discuss
Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard
Show moreTop Buy/Sell (This Month)
| Security | Price | Target price |
|---|---|---|
| Rheinmetall AG | €1,695.0 | €2,000.0 |
| Amazon.com Inc. | €174.16 | €233.52 |
| ServiceNow Inc. | €85.32 | €186.32 |
| Security | Price | Target price |
|---|---|---|
| Factset Research Systems | €161.40 | €171.09 |
| SynBiotic SE | €2.50 | - |
| Franklin Resources Inc. | €22.98 | €18.41 |
New Top predictions since last week
| Prediction | User | Perf. (%) |
|---|---|---|
| B Ocular Therapeutix Inc. | michaelkr | 40.62% |
| B Ocular Therapeutix Inc. | Jefferies Financial Group Inc. | 29.31% |
| B Ocular Therapeutix Inc. | Citigroup Inc. | 21.11% |
| Prediction | User | Perf. (%) |
|---|---|---|
| S DF Deutsche Forfait AG | Lokrim | -79.74% |
| S DF Deutsche Forfait AG | daimler1 | -78.31% |
| S Coreo AG | Wolf_of_WS | -74.54% |
Many tell you which stocks to buy.
We measure how often they are right!
Portfolios of our members
Quantum Emotion Corp.
When it comes to stocks, what is important for you?
Find stocks based on your criteria with our sharewise stock finder. All results are based on thousands of votes by our community
Pros and Cons of these stocks (New Predictions)
MagForce AG
WKN: A0HGQF / Name: MagForce / Stock / Biotechnology & Medical Research / Small Cap /
Pros
Cons
Nektar Therapeutics
WKN: A419UB / Name: Nektar Therapeutics / Stock / ? /
Pros
Cons
Try sharewise+ and get hundreds more matching stocks
Sign up for free!Tops & Flops S&P 500
| Security | Price | Change(%) (%) |
|---|---|---|
| Paypal Holdings Inc | €37.37 | 5.650% |
| Albemarle Corp | €150.60 | 5.180% |
| Discovery Communications C | €22.42 | 5.110% |
| Eli Lilly Corp. | €897.70 | 4.570% |
| Corning Inc. | €123.22 | 4.040% |
| Security | Price | Change(%) (%) |
|---|---|---|
| International Business Machines Corp | €189.44 | -13.170% |
| Zebra Technologies A | €196.30 | -9.410% |
| Bath & Body Works Inc. | €19.11 | -9.030% |
| Macy's Inc. | €18.05 | -8.690% |
| Lincoln National | €30.27 | -8.510% |
Courses
sharewise advanced features
Also you get more information about our Pro and Cons feature, where we bring the wisdom of crowds to a new level.
For discussing with your friends and managing your investment clubs we will show you how to create your own stock debates.#
Get started on the stock market in these easy steps
Things you will learn:
- What is a stock
- What is a fund
- What is an ETF
- How to open a depot
- How to manage a depot that will regularly beat managed funds
- Why you mostly need patience to succeed on the stock market
Predictions
Top News
3 Major Buybacks Just Dropped—Here’s the Signal Investors See
Several major companies just expanded their share repurchase authorizations, giving them fresh capacity to retire stock in 2026. In a market where buybacks matter more than ever for per-share
3 of the Most Highly Anticipated IPOs of 2026
Last year, the initial public offering (IPO) landscape was dominated by names operating in tech, and specifically, fintech. But this year, the list of companies rumored to be seeking public
AirJoule Has Big Partners—So What’s Still Holding the Stock Back?
AirJoule Technologies (NASDAQ: AIRJ) is a risky play, as it is a pre-revenue company yet to start sales, which are expected to begin in 2026. The questions are whether the company matters, if its
3 Big Dividend Stocks Just Raised Payouts—Here’s Who’s Leading in 2026
Big dividend names aren’t just maintaining payouts in 2026—they’re raising them. That matters in a market where growth expectations are shifting, rates remain a factor, and investors are paying up
The Supply Chain Quietly Powering the AI Boom—And 4 Ways to Play It
Artificial intelligence has dominated market headlines for more than a year. Investors have chased chip designers, data center operators, and software platforms powering large language models. But
Tennant (TNC) Lags Q4 Earnings and Revenue Estimates
Tennant (TNC) came out with quarterly earnings of $1.39 per share, missing the Zacks Consensus Estimate of $1.68 per share. This compares to earnings of $1.52 per share a year ago. These figures are
Compared to Estimates, EverQuote (EVER) Q4 Earnings: A Look at Key Metrics
For the quarter ended December 2025, EverQuote (EVER) reported revenue of $195.32 million, up 32.5% over the same period last year. EPS came in at $1.54, compared to $0.33 in the year-ago quarter.
Atlas Energy Solutions Inc. (AESI) Reports Q4 Earnings: What Key Metrics Have to Say
For the quarter ended December 2025, Atlas Energy Solutions Inc. (AESI) reported revenue of $249.43 million, down 8.1% over the same period last year. EPS came in at -$0.22, compared to $0.06 in the
Compared to Estimates, Black Stone Minerals (BSM) Q4 Earnings: A Look at Key Metrics
Black Stone Minerals (BSM) reported $118.7 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 41.8%. EPS of $0.31 for the same period compares to $0.18
Ovintiv (OVV) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended December 2025, Ovintiv (OVV) reported revenue of $2.15 billion, down 1.9% over the same period last year. EPS came in at $1.39, compared to $1.35 in the year-ago quarter.
The
Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Beats Revenue Estimates
Vir Biotechnology, Inc. (VIR) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.42. This compares to a loss of $0.76 per share a year ago. These
News
Douglas Dynamics (PLOW) Surpasses Q4 Earnings and Revenue Estimates
Douglas Dynamics (PLOW) came out with quarterly earnings of $0.62 per share, beating the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $0.39 per share a year ago. These
Primoris Services (PRIM) Tops Q4 Earnings and Revenue Estimates
Primoris Services (PRIM) came out with quarterly earnings of $1.08 per share, beating the Zacks Consensus Estimate of $0.95 per share. This compares to earnings of $1.13 per share a year ago. These
Diversified Healthcare (DHC) Misses Q4 FFO and Revenue Estimates
Diversified Healthcare (DHC) came out with quarterly funds from operations (FFO) of $0.09 per share, missing the Zacks Consensus Estimate of $0.12 per share. This compares to FFO of $0.02 per share
Helix Energy (HLX) Q4 Earnings and Revenues Top Estimates
Helix Energy (HLX) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to earnings of $0.13 per share a year ago
EverQuote (EVER) Q4 Earnings and Revenues Surpass Estimates
EverQuote (EVER) came out with quarterly earnings of $1.54 per share, beating the Zacks Consensus Estimate of $0.35 per share. This compares to earnings of $0.33 per share a year ago. These figures
Ovintiv (OVV) Q4 Earnings and Revenues Surpass Estimates
Ovintiv (OVV) came out with quarterly earnings of $1.39 per share, beating the Zacks Consensus Estimate of $0.98 per share. This compares to earnings of $1.35 per share a year ago. These figures are
Brighthouse Financial (BHF) Q4 Earnings and Revenues Miss Estimates
Brighthouse Financial (BHF) came out with quarterly earnings of $3.93 per share, missing the Zacks Consensus Estimate of $5.19 per share. This compares to earnings of $5.88 per share a year ago
Atlas Energy Solutions Inc. (AESI) Reports Q4 Loss, Tops Revenue Estimates
Atlas Energy Solutions Inc. (AESI) came out with a quarterly loss of $0.22 per share in line with the Zacks Consensus Estimate. This compares to earnings of $0.06 per share a year ago. These figures
Here's What Key Metrics Tell Us About Myriad (MYGN) Q4 Earnings
For the quarter ended December 2025, Myriad Genetics (MYGN) reported revenue of $209.8 million, down 0.4% over the same period last year. EPS came in at $0.04, compared to $0.03 in the year-ago
Contest
Still running
sharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.
Heibel Ticker
sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.
Kostenlos ausprobieren
Leeway
Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.